(EN) Throughout my research career I have been interested in how a better understanding of fundamental immunology can be applied to novel solutions for improving human health. I undertook a PhD in immunological memory, and with progression of my career moved closer to translational research to deliver research findings to the clinic. During my post-doctoral positions I worked on vaccine development projects for HIV and TB to understand how different vaccination strategies impact innate and adaptive immunity. More recently I have focused on biomarkers that are predictive of spontaneous clearance and response to therapy for Hepatitis C patients. This approach is helping us to understand what is required for a protective immune response to HCV while at the same time giving us unique tools to help manage therapeutic decisions. My current focus as scientific manager of the LabEx Milieu Interieur project at Institut Pasteur, Paris is to understand the genetic and environmental determinants of a healthy immune response, and also apply these findings to disease settings to develop new diagnostic and therapeutic approaches.
Cliquez pour voir le graph
Connexions
Cliquez pour voir la ligne de temps
Ligne de temps
Cours
10th HKU-Pasteur Immunology Course: December 2-15, 2018
‘Quantitative Immunology’ will be the theme of the 10th anniversary of the HKU-Pasteur Immunology Course. We will explore the ongoing transition from reductionist studies, based on the application of genetic approaches in animal models, […]
2018-12-02 09:00:00
2018-12-15 18:00:00
Europe/Paris
10th HKU-Pasteur Immunology Course: December 2-15, 2018
‘Quantitative Immunology’ will be the theme of the 10th anniversary of the HKU-Pasteur Immunology Course. We will explore the ongoing transition from reductionist studies, based on the application of genetic approaches in animal models, […]
HKU-Pasteur Research Centre, Hong Kong
Projets Transversaux
Projets
CV
Publications
Télécharger-
2019Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth, Nat. Immunol. 2019 Mar;20(3):257-264.
-
2018Reverse-Transcriptase Inhibitors in the Aicardi–Goutières Syndrome, N. Engl. J. Med. 2018 12;379(23):2275-7.
-
2018A child with severe juvenile dermatomyositis treated with ruxolitinib, Brain 2018 Nov;141(11):e80.
-
2018Efficacy of JAK1/2 inhibition in the treatment of chilblain lupus due to TREX1 deficiency, Ann. Rheum. Dis. 2018 Oct;.
-
2018Immune response biomarkers in human and veterinary research, Comp. Immunol. Microbiol. Infect. Dis. 2018 Aug;59:57-62.
-
2018Potential utility of the Genedrive point-of-care test for HCV RNA detection, Gut 2018 Sep;.
-
2018First description of agonist and antagonist IP-10 in urine of patients with active TB, Int. J. Infect. Dis. 2019 Jan;78:15-21.
-
2018Human thymopoiesis is influenced by a common genetic variant within the locus, Sci Transl Med 2018 Sep;10(457).
-
2018Human genetic variants and age are the strongest predictors of humoral immune responses to common pathogens and vaccines, Genome Med 2018 07;10(1):59.
-
2018Mitochondrial double-stranded RNA triggers antiviral signalling in humans, Nature 2018 08;560(7717):238-242.
-
+Voir la liste complète de publications